List of corporate sponsors

We thank our corporate sponsors for making the work of fighting kidney disease on all fronts possible. These organizations help ensure that every kidney patient has access to health care and every person at risk for this chronic health condition is empowered to prevent it.

Meeting in an office conference room

Thank you to our major corporate sponsors

The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more. You can also view our Corporate Members here.

($500,000+)

AstraZeneca Pharmaceuticals LP

GlaxoSmithKline

($100,000–$499,999)

Akebia Therapeutics, Inc.

Alnylam Pharmaceuticals, Inc.

Amgen USA

Cara Therapeutics

DaVita Healthcare Partners, Inc 

FMC Renal Pharmaceuticals

Horizon Therapeutics

Otsuka America Pharmaceutical Inc.

Tricida Inc

Vertex, Inc.

($50,000–$99,999)

Abbott Nutrition

Alexion Pharmaceuticals, Inc.

Ardelyx, Inc.

Rockpointe Corporation

Satellite Healthcare Inc

Truist Foundation - formerly Suntrust

($25,000–$49,999)

Gentian

Quest Diagnostics

Relypsa, Inc.

Right Advisory LLC

Travere

($5,000–$24,999)

American Society of Nephrology

Apellis Pharmaceuticals, Inc.

Aurinia Biotechnology Innovation Organization (BIO)

ColorNet Printing & Graphics

Dime Community Bank

EventEQ

Federal Street Strategies LLC

Flushing Bank

Fresenius Medical Care Institute for Advanced Clinical Trials for Children

Interactive Strategies

Jaspan Schlesinger LLP

JPA Health Communications

King & Spalding LLP

Latham & Watkins

Mallinckrodt Inc.

Mercury Public Affairs

Natera

National Renal Administrators Association

Northleaf Capital Partners

Omeros Corporation

OPKO Health - Renal Division

Orases PhRMA

PROTEK Consulting

RKD Group

Rockwell Medical Technologies Inc

Satter Investment Management

SPG Fiduciary Partners of Raymond James

Spherix Global Insights

SplitOak Strategies LLC

The Cooking Doc, LLC 

The Meltzer Group NFP

Vendorin York Studios  

Pharmaceutical Funding

  • The total pharmaceutical revenue including donated product is $5,361,700
  • The percentage of revenue from pharmaceutical companies is 1.59%

Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.

Explore corporate partnership opportunities

Con el AKF, su ayuda llega más lejos

Esto fue lo que lograron en 2021 sus donaciones al AKF.

1,673 low-income dialysis patients

1,673 low-income dialysis patients

had kidney transplants and post-transplant care with AKF's financial support in 2025

75,000 dialysis and recent transplant patients

75,000 dialysis and recent transplant patients

were able to afford health care coverage and other treatment-related expenses.

Over $2.7 million in grants

Over $2.7 million in grants

provided through our Safety Net Program to nearly 15,000 people living with kidney failure.

More than 50,000 AKF Ambassadors

More than 50,000 AKF Ambassadors

from all 50 states and D.C. participated in our Advocacy Network, fighting for issues of importance to the kidney community.

More than 8,000 kidney health coaches

More than 8,000 kidney health coaches

completed our training course to educate others about the importance of living a healthy lifestyle.

144 kids and teens

144 kids and teens

connected with their peers in Camp Connections for pediatric kidney patients.